Reata Pharmaceuticals Inc - A 級
US ˙ NASDAQ ˙ US75615P1030
該符號不再有效

SecurityRETA / Reata Pharmaceuticals Inc - Class A
InstitutionBarclays Plc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Barclays Plc ownership in RETA / Reata Pharmaceuticals Inc - Class A

On March 26, 2026 - Barclays Plc filed a 13F-HR/A form disclosing ownership of 0 shares of Reata Pharmaceuticals Inc - Class A (US:RETA) valued at $0 USD as of September 30, 2023. The entity filed a previous 13F-HR/A on March 30, 2026 disclosing 79,034 shares of Reata Pharmaceuticals Inc - Class A. The current value of the position is $0 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (RETA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RETA / Reata Pharmaceuticals Inc - Class A Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-03-26 2023-09-30 13F/A-1 REATA PHARMACEUTICALS COM 75615P103 0 -100.00 0
2023-11-07 2023-09-30 13F REATA PHARMACEUTICALS COM 75615P103 0 -79,034 -100.00 0 -100.00
2026-03-30 2023-06-30 13F/A-2 REATA PHARMACEUTICALS COM 75615P103 79,034 79,034 8,058 0.0012
2023-09-20 2023-06-30 13F/A-1 REATA PHARMACEUTICALS COM 75615P103 79,034 62,278 371.68 8 700.00 0.0051
2023-08-03 2023-06-30 13F REATA PHARMACEUTICALS COM 75615P103 79,034 62,278 8 0.0051
2026-03-30 2023-03-31 13F/A-1 REATA PHARMACEUTICALS COM 75615P103 16,756 886 5.58 1,523 152.99 0.0002
2026-03-30 2023-03-31 13F/A-1 REATA PHARMACEUTICALS COM 75615P103 0 -100.00 0
2023-05-04 2023-03-31 13F REATA PHARMACEUTICALS COM 75615P103 16,756 886 5.58 2 0.0007
2026-03-30 2022-12-31 13F/A-1 REATA PHARMACEUTICALS COM 75615P103 15,870 2,008 14.49 603 72.99 0.0001
2023-02-13 2022-12-31 13F REATA PHARMACEUTICALS COM 75615P103 15,870 2,008 14.49 1 -100.00 0.0000
2022-11-03 2022-09-30 13F REATA PHARMACEUTICALS COM 75615P103 13,862 -1,769 -11.32 348 -26.74 0.0004
2022-08-12 2022-06-30 13F REATA PHARMACEUTICALS COM 75615P103 15,631 -13,279 -45.93 475 -49.89 0.0003
2022-05-16 2022-03-31 13F REATA PHARMACEUTICALS COM 75615P103 28,910 -31,981 -52.52 948 -41.01 0.0007
2022-02-23 2021-12-31 13F/A-1 REATA PHARMACEUTICALS COM 75615P103 60,891 35,192 136.94 1,607 -37.83 0.0006
2022-02-14 2021-12-31 13F REATA PHARMACEUTICALS COM 75615P103 60,891 35,192 1,607 0.0002
2021-11-09 2021-09-30 13F REATA PHARMACEUTICALS COM 75615P103 25,699 20,801 424.68 2,585 273.02 0.0012
2021-08-13 2021-06-30 13F REATA PHARMACEUTICALS COM 75615P103 4,898 -2,959 -37.66 693 -11.61 0.0003
2021-05-13 2021-03-31 13F REATA PHARMACEUTICALS COM 75615P103 7,857 5,816 284.96 784 211.11 0.0004
2021-02-11 2020-12-31 13F REATA PHARMACEUTICALS COM 75615P103 2,041 -302 -12.89 252 10.04 0.0001
2020-11-12 2020-09-30 13F REATA PHARMACEUTICALS COM 75615P103 2,343 -17,586 -88.24 229 -92.64 0.0001
2020-08-12 2020-06-30 13F REATA PHARMACEUTICALS COM 75615P103 19,929 -11,682 -36.96 3,111 -31.84 0.0024
2020-05-13 2020-03-31 13F REATA PHARMACEUTICALS COM 75615P103 31,611 -2,794 -8.12 4,564 -35.12 0.0036
2020-02-10 2019-12-31 13F REATA PHARMACEUTICALS COM 75615P103 34,405 24,495 247.17 7,034 783.67 0.0039
2019-11-15 2019-09-30 13F/A-1 REATA PHARMACEUTICALS COM 75615P103 9,910 -3,062 -23.60 796 -34.97 0.0005
2019-11-14 2019-09-30 13F REATA PHARMACEUTICALS COM 75615P103 9,910 -3,062 796 184.0361
2019-08-14 2019-06-30 13F REATA PHARMACEUTICALS COM 75615P103 12,972 -785 -5.71 1,224 4.08 0.0007
2019-05-15 2019-03-31 13F REATA PHARMACEUTICALS COM 75615P103 13,757 4,173 43.54 1,176 118.99 0.0008
2019-02-14 2018-12-31 13F REATA PHARMACEUTICALS COM 75615P103 9,584 2,511 35.50 537 -7.09 0.0004
2018-11-14 2018-09-30 13F REATA PHARMACEUTICALS COM 75615P103 7,073 5,905 505.57 578 1,309.76 0.0004
2018-08-14 2018-06-30 13F REATA PHARMACEUTICALS COM 75615P103 1,168 -3,048 -72.30 41 -52.87 0.0000
2018-05-15 2018-03-31 13F REATA PHARMACEUTICALS COM 75615P103 4,216 720 20.59 87 -12.12 0.0001
2018-02-14 2017-12-31 13F REATA PHARMACEUTICALS COM 75615P103 3,496 -432 -11.00 99 -18.85 0.0001
2017-11-14 2017-09-30 13F REATA PHARMACEUTICALS COM 75615P103 3,928 3,734 1,924.74 122 1,933.33 0.0001
2017-08-14 2017-06-30 13F REATA PHARMACEUTICALS COM 75615P103 194 16 8.99 6 50.00 0.0000
2017-05-15 2017-03-31 13F REATA PHARMACEUTICALS COM 75615P103 178 -803 -81.86 4 -80.95 0.0000
2017-02-14 2016-12-31 13F REATA PHARMACEUTICALS COM 75615P103 981 944 2,551.35 21 2,000.00 0.0000
2016-11-14 2016-09-30 13F REATA PHARMACEUTICALS COM 75615P103 37 -6,047 -99.39 1 -99.17 0.0000
2016-08-12 2016-06-30 13F REATA PHARMACEUTICALS COM 75615P103 6,084 6,084 120 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-12 2020-09-30 13F REATA PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-12 2020-06-30 13F REATA PHARMACEUTICALS OPT Call 13,000 0.00 2,028 8.10 n/a n/a n/a
2020-05-13 2020-03-31 13F REATA PHARMACEUTICALS OPT Call 13,000 1,876 n/a n/a n/a
2020-02-10 2019-12-31 13F REATA PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-15 2019-09-30 13F/A REATA PHARMACEUTICALS OPT Call 15,000 0.00 1,204 -14.91 n/a n/a n/a
2019-11-14 2019-09-30 13F REATA PHARMACEUTICALS OPT Call 15,000 1,204 n/a n/a n/a
2019-08-14 2019-06-30 13F REATA PHARMACEUTICALS OPT Call 15,000 1,415 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-02-10 2019-12-31 13F REATA PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-15 2019-09-30 13F/A REATA PHARMACEUTICALS OPT Put 20,000 0.00 1,606 -14.89 n/a n/a n/a
2019-11-14 2019-09-30 13F REATA PHARMACEUTICALS OPT Put 20,000 1,606 n/a n/a n/a
2019-08-14 2019-06-30 13F REATA PHARMACEUTICALS OPT Put 20,000 1,887 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.